Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Alkem Laboratories LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:539523NSE Symbol: ALKEMP/E(TTM):35.8
ISIN Demat:INE540L01014Div & Yield %:0.97EPS(TTM):143.82
Book Value(Rs):848.50023Market Cap ( Cr.):61555.65Face Value(Rs):2
    Change Company 
( In Cr)
 Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018
INCOME :      
Sales Turnover 9054.558829.817219.686677.085714.095281.01
Excise Duty0.000.000.000.000.000.00
Net Sales9054.558829.817219.686677.085714.095281.01
Other Income 266.29199.89190.0195.9867.58100.91
Stock Adjustments -257.73360.90301.2933.69-86.5691.42
Total Income9063.119390.607710.986806.755695.115473.34
EXPENDITURE :      
Raw Materials 3572.913926.792966.312584.252185.312166.64
Power & Fuel Cost126.32129.53100.12106.0899.0992.82
Employee Cost 1516.221434.491158.721066.76960.09861.63
Other Manufacturing Expenses 361.12399.80280.51276.78270.72256.75
Selling and Administration Expenses 1743.831438.801007.421160.901013.41955.49
Miscellaneous Expenses 99.4750.9471.7448.3553.2065.70
Less: Pre-operative Expenses Capitalised0.000.000.000.000.000.00
Total Expenditure7419.877380.355584.825243.124581.824399.03
Operating Profit1643.242010.252126.161563.631113.291074.31
Interest 86.4037.9042.9338.7128.2632.37
Gross Profit1556.841972.352083.231524.921085.031041.94
Depreciation229.85218.98198.93186.84141.07107.65
Profit Before Tax1326.991753.371884.301338.08943.96934.29
Tax227.52303.82331.83246.95200.41201.66
Fringe Benefit tax0.000.000.000.000.000.00
Deferred Tax-35.00-91.70-132.61-173.29-56.2916.79
Reported Net Profit1134.471541.251685.081264.42799.84715.84
Extraordinary Items -10.241.8216.493.07-1.430.43
Adjusted Net Profit1144.711539.431668.591261.35801.27715.41
Adjst. below Net Profit 0.000.000.00-73.21-36.45-36.51
P & L Balance brought forward6823.395700.624350.323517.812933.772433.80
Statutory Appropriations 0.000.000.000.000.000.00
Appropriations 526.09418.48334.78358.70179.35179.35
P & L Balance carried down7431.776823.395700.624350.323517.812933.78
Dividend0.000.000.000.0095.6571.74
Preference Dividend0.000.000.000.000.000.00
Equity Dividend %2500.001700.001500.001250.00800.00650.00
Earnings Per Share-Unit Curr94.90128.92140.95105.7666.9059.88
Earnings Per Share(Adj)-Unit Curr94.90128.92140.95105.7666.9059.88
Book Value-Unit Curr782.09731.38637.87525.34457.15408.65